MEVIS MEDSOL N
MEVIS MEDSOL N operates in Diversified Metals & Mining.
Market Cap & Net Worth: MEVIS MEDSOL N (M3V)
MEVIS MEDSOL N (BE:M3V) has a market capitalization of $230.07K (€224.14K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #38921 globally and #5395 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEVIS MEDSOL N's stock price €24.20 by its total outstanding shares 9262 (9.26K).
MEVIS MEDSOL N Market Cap History: 2015 to 2025
MEVIS MEDSOL N's market capitalization history from 2015 to 2025. Data shows growth from $200.19K to $230.07K (1.99% CAGR).
MEVIS MEDSOL N Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEVIS MEDSOL N's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
MEVIS MEDSOL N's market cap is 0.01 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.05x
MEVIS MEDSOL N's market cap is 0.05 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $338.64K | $18.54 Million | $5.62 Million | 0.02x | 0.06x |
| 2018 | $262.25K | $16.76 Million | $7.17 Million | 0.02x | 0.04x |
| 2019 | $254.47K | $18.07 Million | $8.07 Million | 0.01x | 0.03x |
| 2020 | $284.88K | $17.13 Million | $5.70 Million | 0.02x | 0.05x |
| 2021 | $283.06K | $16.21 Million | $4.55 Million | 0.02x | 0.06x |
| 2022 | $319.58K | $18.76 Million | $7.79 Million | 0.02x | 0.04x |
| 2023 | $228.27K | $17.34 Million | $4.92 Million | 0.01x | 0.05x |
Competitor Companies of M3V by Market Capitalization
Companies near MEVIS MEDSOL N in the global market cap rankings as of March 19, 2026.
Key companies related to MEVIS MEDSOL N by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
MEVIS MEDSOL N Historical Marketcap From 2015 to 2025
Between 2015 and today, MEVIS MEDSOL N's market cap moved from $200.19K to $ 230.07K, with a yearly change of 1.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €230.07K | -0.82% |
| 2024 | €231.98K | +1.62% |
| 2023 | €228.27K | -28.57% |
| 2022 | €319.58K | +12.90% |
| 2021 | €283.06K | -0.64% |
| 2020 | €284.88K | +11.95% |
| 2019 | €254.47K | -2.97% |
| 2018 | €262.25K | -22.56% |
| 2017 | €338.64K | +3.99% |
| 2016 | €325.66K | +62.68% |
| 2015 | €200.19K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of MEVIS MEDSOL N was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $230.07K USD |
| MoneyControl | $230.07K USD |
| MarketWatch | $230.07K USD |
| marketcap.company | $230.07K USD |
| Reuters | $230.07K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.